Enhanced recovery after surgery promotes postoperative recovery of patients receiving robot assisted laparoscopic insulinoma enucleation

Abstract

Abstract: Objective To compare the postoperative recovery of patients receiving robotic laparoscopic insulinoma enucleation before and after implementing enhanced recovery after surgery (ERAS) protocol. Methods Anesthetic data of patients who received robotic laparoscopic insulinoma enucleation from January 2013 to March 2016 in Peking Union Medical College Hospital were collected and analyzed. All patients were be divided into routine group and ERAS group. Results The study enrolled 68 patients, whose obesity rate was 69.1%. The intraoperative fluid volume of ERAS group was lower than that of the routine group (P＜0.05), while the difference of urine output was not significant. The maximum peak airway pressure of ERAS group was also lower than that in the routine group(P＜0.05). The postoperative hospital stay length of ERAS group was shorter (P＜0.05). The postoperative complications were uncommon in the ERAS group. Conclusions ERAS protocol can shorten the hospital stay length of patients receiving robotic laparoscopic insulinoma enuleation and postoperative complications are likely to be reduced.

Key words: robotic surgical system, insulinoma, enhanced recovery after surgery, obesity

CLC Number:

R614.2

MA Man-jiao, ZHANG Xiu-hua, LIU Zi-jia, WU Wen-ming, ZHAO Yu-pei. Enhanced recovery after surgery promotes postoperative recovery of patients receiving robot assisted laparoscopic insulinoma enucleation[J]. Basic & Clinical Medicine, 2020, 40(4): 543-546.

References

[1]Altman AD, Helpman L, McGee J, et al. Enhanced recovery after surgery: implementing a new standard of surgical care[J]. CMAJ, 2019, 191:E469-E475.
[2]Lassen K, Coolsen MM, Slim K, et al. Guidelines for perioperative care for pancreaticoduodenectomy: enhanced recovery after surgery (ERAS) society recommendations[J]. Clin Nutr, 2012, 31:817-830.
[3]Ljungqvist O, Scott M, Fearon KC. Enhanced recovery after surgery: a review[J]. JAMA Surg, 2017, 152:292-298.
[4]Simpson JC, Bao X, Agarwala A. Pain management in enhanced recovery after surgery (ERAS) protocols[J]. Clin Colon Rectal Surg, 2019, 32:121-128.
[5]Maund E, McDaid C, Rice S, et al. Paracetamol and selective and non-selective non-steroidal anti-inflammatory drugs for the reduction in morphine-related side-effects after major surgery: a systematic review[J]. Br J Anaesth, 2011, 106:292-297.
[6]Laks S, Isaak RS, Strassle PD, et al. Increased intraoperative vasopressor use as part of an enhanced recovery after surgery pathway for pancreatectomy does not increase risk of pancreatic fistula[J]. J Pancreat Cancer, 2018, 4:33-40.
[7]Phan TD, D'Souza B, Rattray MJ, et al. A randomised controlled trial of fluid restriction compared to oesophageal doppler-guided goal-directed fluid therapy in elective major colorectal surgery within an enhanced recovery after surgery program[J]. Anaesth Intensive Care, 2014, 42:752-760.
[8]Sierzega M, Choruz R, Pietruszka S, et al. Feasibility and outcomes of early oral feeding after total gastrectomy for cancer[J]. J Gastrointest Surg, 2015, 19:473-479.
[9]Cassidy MR, Rosenkranz P, McAneny D. Reducing postoperative venous thromboembolism complications with a standardized risk-stratified prophylaxis protocol and mobilization program[J]. J Am Coll Surg, 2014, 218:1095-1104.
[10]Short V, Herbert G, Perry R, et al.Chewing gum for postoperative recovery of gastrointestinal function[J]. Cochrane Database Syst Rev, 2015. doi: 10.1002/14651858.CD006506.pub3.

[1]	Jazyra ZYNAT, LI Suli, ZHANG Kaidi, MA Fuhui, MA Guoying, GUO Yanying. Association of T helper cells and cytokines with abdominal obesity in Hashimoto′s thyroiditis [J]. Basic & Clinical Medicine, 2024, 44(8): 1120-1125.
[2]	DING Baofeng, WANG Xiaoshuang, WANG Fang, YU Jia. Pathological changes and metabolome analysis of liver in obese mouse models [J]. Basic & Clinical Medicine, 2024, 44(5): 699-704.
[3]	ZHANG Liyuan, DU Hanze, PAN Hui. Progress in drug therapy for hypothalamic obesity [J]. Basic & Clinical Medicine, 2024, 44(5): 729-732.
[4]	LU Huiying, WANG Jianguo. Downregulation of demethylase FTO inhibits proliferation of human liver cancer cell line HepG2 [J]. Basic & Clinical Medicine, 2024, 44(2): 185-191.
[5]	ZHU Qianmei, LIU Zijia, TAN Gang, SHEN Le, HUANG Yuguang. Exploration and practice of Enhanced Recovery after Surgery and Perioperative Management course in postgraduate teaching [J]. Basic & Clinical Medicine, 2024, 44(2): 276-280.
[6]	LIAO Zhencheng, YANG Siyi, WU Ping'an. Increased expression of m⁶A demethylase FTO inhibits the proliferation of nasopharyngeal carcinoma cells [J]. Basic & Clinical Medicine, 2024, 44(1): 57-62.
[7]	MA Guoying, Jiazireya·ZAIYINATI, LI Suli, GUO Yanying. Analysis of differentially expressed proteins in Hashimoto thyroiditis patients with obesity by serum-based proteomics [J]. Basic & Clinical Medicine, 2023, 43(9): 1375-1382.
[8]	CHEN Xin, CHEN Jun, XU Xing, WANG Xu. Histone demethylase inhibitor GSK-J4 reduces body weight in high-fat diet-induced obese mice [J]. Basic & Clinical Medicine, 2023, 43(9): 1353-1358.
[9]	WANG Xinrui, QIN Yan. Research advances of Ghrelin in metabolic diseases [J]. Basic & Clinical Medicine, 2023, 43(8): 1299-1303.
[10]	ZHANG Jing, WU Kai, HUANG Wei. High expression of hsa_circ_0017650 in human adipocyte differentiation process and adipose tissue of obese people [J]. Basic & Clinical Medicine, 2023, 43(7): 1079-1083.
[11]	JIANG Chenchen, CUI Ze, PAN Li, SUN Jixin, HE Huijing, HU Yaoda, SHAN Guangliang. Interaction of family history of hypertension and overweight/obesity on hypertension in Han and Manchu adults in Hebei province [J]. Basic & Clinical Medicine, 2023, 43(7): 1053-1059.
[12]	DONG Dexin, ZHANG Yushi, YAN Weigang, SHI Bingbing. Application of improved enhanced recovery after surgery in laparoscopic partial nephrectomy [J]. Basic & Clinical Medicine, 2023, 43(11): 1702-1706.
[13]	HU Shi-qi, LAN Yan-qi, WU Shou-ling, WANG Xiao-mo, CHEN Shuo-hua, WANG Guo-dong, WANG Li. Effect of obesity and obesity trajectories on the risk of cardiovascular diseases in adult male with incident NAFLD in Northern China [J]. Basic & Clinical Medicine, 2022, 42(5): 788-794.
[14]	LI Yan,LIU Tao-di,ZHOU Hao-le. Research progress on the role of TRIB3 in obesity pathogenesis [J]. Basic & Clinical Medicine, 2021, 41(9): 1352-1355.
[15]	SHU Feng, WANG Meng-yi, ZHANG Shi-wu, LI Qian-zhu, ZHANG Wei-hua. Research progress of inflammatory response of adipose tissue [J]. Basic & Clinical Medicine, 2021, 41(7): 1052-1055.